Related Experiment Video
Updated: May 11, 2026

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Cardiac resynchronization therapy improves altered Na channel gating in canine model of dyssynchronous heart failure
Takeshi Aiba1, Andreas S Barth, Geoffrey G Hesketh
1Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
Insights
Cardiac resynchronization therapy (CRT) normalizes sodium channel function in heart failure by reducing late sodium current (INa-L), shortening action potential duration, and preventing arrhythmias. This study explores the underlying molecular mechanisms involving CaMKII.
Area of Science:
- Cardiovascular Physiology
- Cardiac Electrophysiology
- Molecular Cardiology
Background:
- Dyssynchronous heart failure (DHF) is associated with slowed sodium current (INa) decay and enhanced late INa (INa-L), prolonging action potential duration (APD) and causing early afterdepolarizations.
- Cardiac resynchronization therapy (CRT) shortens APD in DHF, but its effects on Na+ channel gating are not well understood.
Purpose of the Study:
- To investigate the impact of CRT on Na+ channel gating abnormalities in a canine model of DHF.
- To explore the role of phosphorylated Ca2+/Calmodulin protein kinase II (pCaMKII) in mediating CRT's effects on Na+ channels.
Main Methods:
- Adult dogs were subjected to DHF (left-bundle branch ablation and pacing) or CRT (DHF followed by biventricular pacing).
- INa and INa-L were measured in left ventricular myocytes.
- A canine action potential model was used to simulate the effects of INa-L alterations.
Main Results:
- DHF altered Na+ channel availability and slowed recovery from inactivation, while markedly increasing INa-L.
- CRT reversed some DHF-induced gating changes and dramatically reduced INa-L, abbreviating APD and suppressing early afterdepolarizations.
- CRT was linked to reduced pCaMKII levels, suggesting a molecular pathway for Na+ channel regulation.
Conclusions:
- CRT effectively improves DHF-induced Na+ channel dysfunction, particularly by suppressing INa-L, leading to APD abbreviation and reduced early afterdepolarizations.
- Reduced pCaMKII levels represent a potential molecular mechanism through which biventricular pacing regulates cardiac Na+ channels in heart failure.
Background:
Slowed Na⁺ current (INa) decay and enhanced late INa (INa-L) prolong the action potential duration (APD) and contribute to early afterdepolarizations. Cardiac resynchronization therapy (CRT) shortens APD compared with dyssynchronous heart failure (DHF); however, the role of altered Na⁺ channel gating in CRT remains unexplored.
Methods And Results:
Adult dogs underwent left-bundle branch ablation and right atrial pacing (200 beats/min) for 6 weeks (DHF) or 3 weeks followed by 3 weeks of biventricular pacing at the same rate (CRT). INa and INa-L were measured in left ventricular myocytes from nonfailing, DHF, and CRT dogs. DHF shifted voltage-dependence of INa availability by -3 mV compared with nonfailing, enhanced intermediate inactivation, and slowed recovery from inactivation. CRT reversed the DHF-induced voltage shift of availability, partially reversed enhanced intermediate inactivation but did not affect DHF-induced slowed recovery. DHF markedly increased INa-L compared with nonfailing. CRT dramatically reduced DHF-induced enhanced INa-L, abbreviated the APD, and suppressed early afterdepolarizations. CRT was associated with a global reduction in phosphorylated Ca²⁺/Calmodulin protein kinase II, which has distinct effects on inactivation of cardiac Na⁺ channels. In a canine AP model, alterations of INa-L are sufficient to reproduce the effects on APD observed in DHF and CRT myocytes.
Conclusions:
CRT improves DHF-induced alterations of Na⁺ channel function, especially suppression of INa-L, thus, abbreviating the APD and reducing the frequency of early afterdepolarizations. Changes in the levels of phosphorylated Ca²⁺/Calmodulin protein kinase II suggest a molecular pathway for regulation of INa by biventricular pacing of the failing heart.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Heart Failure Drugs: Inotropic Agents
Dysrhythmias VI: Management of Dysrhythmias
Cardiomyopathy V: Interprofessional Care
Heart Failure VI: Adjunct Therapies
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

